Cascorbi, I.
65  results:
Search for persons X
?
1

Genetic and Epigenetic Mechanisms of Tki Resistance:

Cascorbi, I.
Clinical Therapeutics.  39 (2017)  8 - p. e102 , 2017
 
?
2

Epigenetics in Drug Response:

Cascorbi, I ; Schwab, M
Clinical Pharmacology & Therapeutics.  99 (2016)  5 - p. 468-470 , 2016
 
?
3

Pharmacogenomic or ‐epigenomic biomarkers in drug treatment..:

Ingelman‐Sundberg, M ; Cascorbi, I
Clinical Pharmacology & Therapeutics.  99 (2016)  5 - p. 478-480 , 2016
 
?
4

Pharmacological Treatment of Pain: Future Trends and Novel ..:

Cascorbi, I
Clinical Pharmacology & Therapeutics.  97 (2015)  2 - p. 104-108 , 2015
 
?
5

Effects of CYP2B6 genetic polymorphisms in patients receivi..:

Haroun, F. ; Al-Shaar, L. ; Habib, R. H....
Cancer Chemotherapy and Pharmacology.  75 (2014)  1 - p. 207-214 , 2014
 
?
8

Elimination Half-Life of Anti-Müllerian Hormone:

Griesinger, G. ; Dafopoulos, K. ; Buendgen, N....
The Journal of Clinical Endocrinology & Metabolism.  97 (2012)  6 - p. 2160-2163 , 2012
 
?
 
?
10

P048 A CLINICAL TRIAL ON ABSORPTION AND N-ACETYLATION OF OR..:

Dilger, K. ; Trenk, D. ; Rössle, M....
Journal of Crohn's and Colitis Supplements.  1 (2007)  1 - p. 16 , 2007
 
?
11

A clinical trial on absorption and N‐acetylation of oral an..:

Dilger, K. ; Trenk, D. ; Rössle, M....
European Journal of Clinical Investigation.  37 (2007)  7 - p. 558-565 , 2007
 
?
13

PIII-30Single nucleotide polymorphisms in the eNOS and endo..:

UFER, M ; CLAASSEN, J ; BUEHLER, K...
Clinical Pharmacology & Therapeutics.  79 (2006)  2 - p. P66-P66 , 2006
 
?
14

Genetic basis of toxic reactions to drugs and chemicals:

CASCORBI, I
Toxicology Letters.  162 (2006)  1 - p. 16-28 , 2006
 
?
15

OV-A-2Inducibility of UGT1A1 mrna is dependent on UGT1A1⁎28..:

CASCORBI, I ; REMMLER, C ; HAENISCH, S..
Clinical Pharmacology & Therapeutics.  79 (2006)  2 - p. P34-P34 , 2006
 
1-15